Institutional Manager · CIK 0001858703
Blue Owl Capital Holdings LP
New York, NY · File #028-21866
Latest AUM
$1.34B
Positions
83
Top-10 Concentration
62.0%
Filings
13
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORT (Amended)Q/E Dec 202583 pos · $324.0M
- 13F HOLDINGS REPORTQ/E Dec 202583 pos · $1.34B
- 13F HOLDINGS REPORTQ/E Sep 202575 pos · $322.1M
- 13F HOLDINGS REPORTQ/E Jun 202573 pos · $309.9M
- 13F HOLDINGS REPORTQ/E Mar 202574 pos · $310.1M
- 13F HOLDINGS REPORTQ/E Dec 202480 pos · $433.7M
- 13F HOLDINGS REPORTQ/E Sep 2024141 pos · $514.0M
- 13F HOLDINGS REPORTQ/E Jun 202443 pos · $359.6M
- 13F HOLDINGS REPORTQ/E Mar 202449 pos · $500.6M
- 13F HOLDINGS REPORTQ/E Dec 202319 pos · $129.3M
- 13F HOLDINGS REPORTQ/E Sep 202322 pos · $162.3M
- 13F HOLDINGS REPORTQ/E Jun 202319 pos · $156.1M
- 13F HOLDINGS REPORTQ/E Mar 202356 pos · $235.0M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ENGENE HOLDINGS INC | ENGNW | 3,360,937 | $30.3M | 9.40% |
| 2 | NUVEEN CHURCHILL DIRECT LEND | 67090S108 | 2,143,626 | $28.6M | 8.85% |
| 3 | BLUE OWL CAPITAL CORPORATION | OWL | 2,045,070 | $26.1M | 8.09% |
| 4 | LARIMAR THERAPEUTICS INC | LRMR | 6,823,690 | $26.0M | 8.05% |
| 5 | CULLINAN THERAPEUTICS INC | CGEM | 2,350,972 | $24.3M | 7.53% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 3,466,525 | $18.6M | 5.76% |
| 7 | HOLLEY INC | HLLY-WT | 4,146,636 | $17.1M | 5.30% |
| 8 | CONTEXT THERAPEUTICS INC | CNTX | 7,432,906 | $10.9M | 3.38% |
| 9 | CONDUENT INC | CNDT | 4,822,422 | $9.3M | 2.87% |
| 10 | REPARE THERAPEUTICS INC | 760273102 | 3,443,659 | $9.0M | 2.77% |
| 11 | CIVEO CORP | CVEO | 370,530 | $8.5M | 2.62% |
| 12 | SAGIMET BIOSCIENCES INC | SGMT | 1,243,877 | $7.4M | 2.28% |
| 13 | EYEPOINT INC | EYPT | 392,594 | $7.2M | 2.22% |
| 14 | DELL TECHNOLOGIES INC | DELL | 53,848 | $6.8M | 2.10% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 360,000 | $5.8M | 1.80% |
| 16 | MAPLIGHT THERAPEUTICS INC | MPLT | 327,058 | $5.7M | 1.78% |
| 17 | ROIVANT SCIENCES LTD | ROIV | 263,249 | $5.7M | 1.77% |
| 18 | IMAGENEBIO INC | IMA | 823,785 | $5.7M | 1.76% |
| 19 | IMMIX BIOPHARMA INC | IMMX | 986,240 | $5.2M | 1.60% |
| 20 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 212,638 | $4.9M | 1.51% |